TY - JOUR
T1 - Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
AU - Dubinsky, Marla C.
AU - Kugathasan, Subra
AU - Mei, Ling
AU - Picornell, Yoana
AU - Nebel, Justin
AU - Wrobel, Iwona
AU - Quiros, Antonio
AU - Silber, Gary
AU - Wahbeh, Ghassan
AU - Katzir, Lirona
AU - Vasiliauskas, Eric
AU - Bahar, Ron
AU - Otley, Anthony
AU - Mack, David
AU - Evans, Jonathan
AU - Rosh, Joel
AU - Hemker, Maria Oliva
AU - Leleiko, Neal
AU - Crandall, Wallace
AU - Langton, Christine
AU - Landers, Carol
AU - Taylor, Kent D.
AU - Targan, Stephan R.
AU - Rotter, Jerome I.
AU - Markowitz, James
AU - Hyams, Jeffrey
N1 - Funding Information:
The authors would like to acknowledge the research support of the Blinder Research Foundation for Crohn's disease, the Treuman Katz Family Endowment for Crohn's disease and the Irving and Evelyn Feintech Foundations, and Centocor Inc (Malvern, PA).
Funding Information:
Supported by National Institute of Health K23 DK066248 (M.D.), K23 RR016111 (S.K.), IBD Program Project Grant DK 46763 (S.R.T., J.I.R., K.D.T.), The Cedars-Sinai Board of Governors' Chair in Medical Genetics (J.I.R.), and General Clinical Research Center, Grant #MO1-RR00425 (K.D.T.).
PY - 2008/10
Y1 - 2008/10
N2 - Background & Aims: The ability to identify children with CD who are at highest risk for rapid progression from uncomplicated to complicated phenotypes would be invaluable in guiding initial therapy. The aims of this study were to determine whether immune responses and/or CARD15 variants are associated with complicated disease phenotypes and predict disease progression. Methods: Sera were collected from 796 pediatric CD cases and tested for anti-Cbir1 (flagellin), anti-outer membrane protein C, anti-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibody by using enzyme-linked immunosorbent assay. Genotyping (Taqman MGB) was performed for 3 CARD15 variants (single nucleotide polymorphisms 8, 12, and 13). Associations between immune responses (antibody sum and quartile sum score, CARD15, and clinical phenotype were evaluated. Results: Thirty-two percent of patients developed at least 1 disease complication within a median of 32 months, and 18% underwent surgery. The frequency of internal penetrating, stricturing, and surgery significantly increased (P trend < .0001 for all 3 outcomes) with increasing antibody sum and quartile sum score. Nine percent of seropositive groups had internal penetrating/stricturing versus 2.9% in the seronegative group (P = .01). Twelve percent of seropositive groups underwent surgery versus 2% in the seronegative group (P = .0001). The highest antibody sum group (3) and quartile sum score group (4) demonstrated the most rapid disease progression (P < .0001). Increased hazard ratio was observed for antibody sum group 3 (7.8; confidence interval, 2.2-28.7), P < .002 and quartile sum score group 4 (11.0; confidence interval, 1.5-83.0, P < .02). Conclusions: The rate of complicated CD increases in children as the number and magnitude of immune reactivity increase. Disease progression is significantly faster in children expressing immune reactivity.
AB - Background & Aims: The ability to identify children with CD who are at highest risk for rapid progression from uncomplicated to complicated phenotypes would be invaluable in guiding initial therapy. The aims of this study were to determine whether immune responses and/or CARD15 variants are associated with complicated disease phenotypes and predict disease progression. Methods: Sera were collected from 796 pediatric CD cases and tested for anti-Cbir1 (flagellin), anti-outer membrane protein C, anti-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibody by using enzyme-linked immunosorbent assay. Genotyping (Taqman MGB) was performed for 3 CARD15 variants (single nucleotide polymorphisms 8, 12, and 13). Associations between immune responses (antibody sum and quartile sum score, CARD15, and clinical phenotype were evaluated. Results: Thirty-two percent of patients developed at least 1 disease complication within a median of 32 months, and 18% underwent surgery. The frequency of internal penetrating, stricturing, and surgery significantly increased (P trend < .0001 for all 3 outcomes) with increasing antibody sum and quartile sum score. Nine percent of seropositive groups had internal penetrating/stricturing versus 2.9% in the seronegative group (P = .01). Twelve percent of seropositive groups underwent surgery versus 2% in the seronegative group (P = .0001). The highest antibody sum group (3) and quartile sum score group (4) demonstrated the most rapid disease progression (P < .0001). Increased hazard ratio was observed for antibody sum group 3 (7.8; confidence interval, 2.2-28.7), P < .002 and quartile sum score group 4 (11.0; confidence interval, 1.5-83.0, P < .02). Conclusions: The rate of complicated CD increases in children as the number and magnitude of immune reactivity increase. Disease progression is significantly faster in children expressing immune reactivity.
UR - http://www.scopus.com/inward/record.url?scp=52949145981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52949145981&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2008.04.032
DO - 10.1016/j.cgh.2008.04.032
M3 - Article
C2 - 18619921
AN - SCOPUS:52949145981
SN - 1542-3565
VL - 6
SP - 1105
EP - 1111
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 10
ER -